Fig. 2.
Anatomical localisation of areas of decreased metabolic activity in AD patients (p < 0.001, uncorrected, k > 1.86 cm3) for SQA using digital controls (left panel), SQA using conventional controls (middle panel), and the significant additional hypometabolic areas obtained with SQA using digital controls compared to SQA using conventional controls (right panel), projected onto 3D volume rendering, spatially normalised and smoothed into the standard SPM template (T-voxel threshold value of 3.3)